Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
Colorcon
UBS
Medtronic
Fish and Richardson
Citi
Federal Trade Commission
Merck

Generated: April 26, 2018

DrugPatentWatch Database Preview

Lupin Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for LUPIN PHARMS, and what generic and branded alternatives to LUPIN PHARMS drugs are available?

LUPIN PHARMS has ten approved drugs.

There is one tentative approval on LUPIN PHARMS drugs.

Summary for Lupin Pharms
US Patents:0
Tradenames:8
Ingredients:8
NDAs:10

Drugs and US Patents for Lupin Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Pharms SUPRAX cefixime TABLET;ORAL 065130-001 Feb 12, 2004 RX No Yes ➤ Sign Up ➤ Sign Up
Lupin Pharms PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 077917-001 Jan 8, 2008 AB RX No No ➤ Sign Up ➤ Sign Up
Lupin Pharms SUPRAX cefixime FOR SUSPENSION;ORAL 065129-001 Feb 23, 2004 AB RX No No ➤ Sign Up ➤ Sign Up
Lupin Pharms AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 078466-004 Feb 5, 2010 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for LUPIN PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe for Oral Suspension 500 mg/5 mL ➤ Subscribe 2014-07-22
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Medtronic
Cipla
Cerilliant
Chubb
Dow
Harvard Business School
Deloitte
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.